Tuochuan Dong

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

Srđan Verstovšek, Jason Gotlib, Ruben A. Mesa et al. · Journal of Hematology & Oncology · 2017 · 298 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study

Jean‐Jacques Kiladjian, Pierre Zachée, Masayuki Hino et al. · The Lancet Haematology · 2020 · 142 citations · Full text

Medicine, Hematology, Pharmacology +5

Canakinumab with and Without Pembrolizumab in Patients with Resectable Non-Small-Cell Lung Cancer: CANOPY-N Study Design

Pilar Garrido, Jean-Louis Pujol, Edward S. Kim et al. · Future Oncology · 2021 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Study of the Pan-PI3K Inhibitor Buparlisib in Adult Chinese Patients with Advanced Solid Tumors

Yi‐Long Wu, LI ZHANG, Lucia Trandafir et al. · Anticancer Research · 2016 · 20 citations · Full text

Pharmacy, Oncology, Pharmacology +12

A new diagnostic accuracy measure and cut-point selection criterion

Tuochuan Dong, Kristopher Attwood, Alan D. Hutson et al. · Statistical Methods in Medical Research · 2015 · 18 citations

Computing, Biostatistics, Biomedical Imaging +16